ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,027Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 85

$303K Total Retail Price of All Prescriptions

Rank: 14 out of 85

351 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 351 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

20% of this provider’s 351 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 5,078 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
LISINOPRIL 423 285 1 4
OMEPRAZOLE 373 218 2 3
HYDROCODONE-ACETAMINOPHEN 341 214 S3 3 2
LEVOTHYROXINE SODIUM 301 217 4 1
AMLODIPINE BESYLATE 220 167 5 6
CITALOPRAM HBR 205 146 6 8
HYDROCHLOROTHIAZIDE 201 142 7 10
LOVASTATIN 194 112 8 29
FUROSEMIDE 171 149 9 11
WARFARIN SODIUM 170 132 10 25
SIMVASTATIN 168 150 11 5
METFORMIN HCL 165 67 12 7
METOPROLOL TARTRATE 163 102 13 27
PRAVASTATIN SODIUM 162 101 14 14
PROAIR HFA 158 94 15 33
GABAPENTIN 139 51 16 12
FLUTICASONE PROPIONATE 119 71 17 35
POTASSIUM CHLORIDE 117 101 18 15
TRAZODONE HCL 113 72 19 13
TRAMADOL HCL 107 46 20 26
NAPROXEN 90 35 21 80
ATORVASTATIN CALCIUM 82 45 22 40
ADVAIR DISKUS 78 50 23 76
SERTRALINE HCL 75 37 24 17
SPIRIVA 75 53 24 91
RANITIDINE HCL 70 32 26 53
LOSARTAN POTASSIUM 69 45 27 18
RISPERIDONE 68 58 28 20
ZOLPIDEM TARTRATE 66 39 29 9
FLUOXETINE HCL 63 36 30 24
LACTULOSE 63 40 30 116
ATENOLOL 57 32 32 70
TRIAMCINOLONE ACETONIDE 54 24 33 128
GLIPIZIDE 52 32 34 133
METOPROLOL SUCCINATE 51 35 35 23
TAMSULOSIN HCL 51 36 35 67
IBUPROFEN 50 25 37 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.